China Medical GatewayLoading your healthcare gateway…

Coronary Artery Disease in China

Overview

Coronary artery disease (CAD) develops when cholesterol plaque gradually narrows the arteries that supply blood to the heart muscle, limiting oxygen delivery and ranging from stable angina to acute heart attack. It is the leading cause of death worldwide, yet with modern diagnostic tools and revascularization techniques it is also one of the most treatable chronic conditions.

China’s top cardiac centers combine enormous procedural volume with advanced imaging and hybrid operating rooms, allowing every stage of disease — from first diagnostic catheterization to complex multivessel bypass — to be planned and delivered by dedicated heart teams.

Symptoms & Signs

Chest pressure or tightness (angina) triggered by exertion or emotion, typically relieved by rest

Shortness of breath and progressively reduced exercise tolerance

Unexplained fatigue, or atypical chest, jaw, back or epigastric discomfort — especially in women and diabetic patients

Palpitations, sweating and nausea accompanying pain episodes

Heart attack: severe crushing chest pain lasting more than 15 minutes with sweating and collapse — a medical emergency

Many narrowing lesions cause no symptoms until a sudden plaque rupture, which is why screening matters for high-risk patients

Diagnosis

Resting ECG and treadmill exercise stress testing with continuous monitoring

Echocardiography assessing heart muscle function and complications such as ischemic mitral regurgitation

Coronary CT angiography (CCTA) as a non-invasive anatomic roadmap with calcium scoring

Invasive coronary angiography — the gold standard — combined with FFR pressure-wire measurement of borderline lesions

Intravascular ultrasound (IVUS) or OCT imaging defining plaque burden before stenting

Laboratory profiling: lipids, HbA1c, kidney function and high-sensitivity troponin

Treatment Options

Guideline-directed medication as the first line: statins, antiplatelet agents, beta-blockers, ACE inhibitors and rigorous risk-factor control

PCI: balloon angioplasty with drug-eluting stents for significant narrowings, via wrist (radial) access with next-day discharge in selected cases

CABG bypass surgery for complex multivessel or left-main disease, using arterial grafts for superior long-term durability

Hybrid revascularization combining minimally invasive bypass and stenting in the same setting for selected anatomy

Cardiac rehabilitation programs integrating exercise prescription, nutrition and secondary-prevention medication tuning

Chronic total occlusion (CTO) recanalization by dedicated high-volume operators for previously untreatable vessels

Advanced Technologies & Novel Drug

Intravascular imaging (IVUS/OCT) and physiology (FFR, FFR-CT) guiding precise, evidence-based stent placement

Rotational and laser atherectomy for heavily calcified arteries

Robotic-assisted PCI and minimally invasive CABG in hybrid operating rooms

Domestically manufactured novel drug-eluting stents and bioresorbable scaffolds approved in China

Novel lipid-lowering agents including PCSK9 inhibitors and siRNA therapies (incluisiran-class) available at major centers

Hospital & Specialist

Return to Home